Epicore Biosystems Named to Fast Company’s Fourth Annual List of the Next Big Things in Tech

List recognizes groundbreaking advancements redefining the way we work and live.

CAMBRIDGE, Mass., Nov. 19, 2024 /PRNewswire/ — Epicore Biosystems (Epicore), a digital health solutions company developing advanced sweat-sensing wearables, today announced that it has been named to Fast Company‘s fourth annual Next Big Things in Tech list, honoring emerging technology that has a profound impact for industries — from education and sustainability to robotics and artificial intelligence.

This year, 138 technologies developed by established companies, startups, or research teams are featured for their potential to revolutionize the lives of consumers, businesses, and society overall. While not all technologies are available in the market yet, each is reaching key milestones to have a proven impact in the next five years.

Epicore has developed pioneering sweat-sensing wearable solutions that offer real-time insights about hydration, stress, nutrition, and wellness. Epicore’s technology taps into the underlying biochemistry and metabolic health by measuring sweat bio-composition and fluid losses in tandem with traditional digital biomarkers. With the backing of several Fortune 500 customers, this non-invasive technology has been commercialized across the connected worker, sports performance, and clinical trials sectors, enabling hyper-personalized management of hydration and recovery.

“We’re deeply honored to be recognized by Fast Company as part of the Next Big Things in Tech class of 2024,” said Dr. Roozbeh Ghaffari, CEO and co-founder of Epicore. “This recognition underscores the pressing need for disruptive technology to unlock personalized hydration and metabolic health insights for people around the world grappling with the long enduring effects of extreme heat, malnutrition, and climate change.”

“The Next Big Things in Tech provides a fascinating glimpse at near- and long-term technological breakthroughs across a variety of sectors,” says Brendan Vaughan, editor-in-chief of Fast Company. “Spanning everything from semiconductors to agricultural gene editing, the companies featured in this year’s list are tackling some of the world’s most pressing and vexing problems.”

Click here to see the final list.

About Fast Company
Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. The editor-in-chief is Brendan Vaughan. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication, Inc., and can be found online at fastcompany.com.

About Epicore Biosystems
Founded in 2017, Epicore Biosystems is a digital health solutions company developing advanced sweat-sensing wearables that provide real-time personalized hydration and health insights. Their clinically validated biowearable solutions and cloud analytics are deployed globally and licensed by leading Fortune 500 companies, the Department of Defense and the National Institute of Health. To learn more, visit https://www.epicorebiosystems.com/.

View original content to download multimedia:https://www.prnewswire.com/news-releases/epicore-biosystems-named-to-fast-companys-fourth-annual-list-of-the-next-big-things-in-tech-302310130.html

SOURCE Epicore Biosystems, Inc.

Staff

Recent Posts

FendX Signs LOI to Acquire IP and Enter a Supply Agreement For Supply of Eco-Friendly Sponge Wipes for Use in Cleaning High-Touch Surfaces

A synergist opportunity to enhance FendX's current product and IP portfolio to keep surfaces clean.…

26 minutes ago

BioGene Therapeutics Welcomes Professor Mirela Delibegovic, FRSE to Its Scientific Advisory Board

Vancouver, British Columbia--(Newsfile Corp. - November 21, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB:…

26 minutes ago

SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024

Launch of new application enables global access to highly recognized solid tumor profiling assay BOSTON…

2 hours ago

Capital Rx Achieves Place on the Deloitte Technology Fast 500™ for Third Year in a Row

Capital Rx ranks #147 on the 2024 Deloitte Fast 500, the list of North America's…

2 hours ago

Stratus Medical Ranked Number 483 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

MAGNOLIA, Texas, Nov. 21, 2024 /PRNewswire/ -- Stratus® Medical announced it ranked 483 on the…

2 hours ago

111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024

SHANGHAI, Nov. 21, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a…

2 hours ago